BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/7/2014 5:32:00 PM | Browse: 1411 | Download: 1689
 |
Received |
|
2014-03-01 13:06 |
 |
Peer-Review Started |
|
2014-03-01 19:41 |
 |
To Make the First Decision |
|
2014-05-29 19:08 |
 |
Return for Revision |
|
2014-06-03 16:29 |
 |
Revised |
|
2014-06-16 13:57 |
 |
Second Decision |
|
2014-07-22 16:50 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-07-22 17:10 |
 |
Articles in Press |
|
2014-07-22 18:28 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-09-11 10:07 |
 |
Publish the Manuscript Online |
|
2014-10-07 17:32 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Topic Highlights |
Article Title |
Biological therapy for ulcerative colitis: An update
|
Manuscript Source |
Invited Manuscript |
All Author List |
Geom Seog Seo and Soo-Cheon Chae |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Wonkwang University |
|
|
Corresponding Author |
Soo-Cheon Chae, PhD, Professor, Department of Pathology, Wonkwang University School of Medicine, Digestive Disease Research Institute, 460 Iksandae-ro, Iksan, Cheonbuk 570-749, South Korea. chaesc@wonkwang.ac.kr |
Key Words |
Ulcerative colitis; Immune dysfunction; Biological therapy; Remission; Clinical trial; Inflammatory bowel disease |
Core Tip |
In the last two years, the use of the Janus kinase 3 inhibitor (oral tofacitinib) and the ?4?7 integrin blocker (vedolizumab) reportedly achieved good clinical response and remission rates in ulcerative colitis patients. Thus, we believe that the detailed investigation of various studies on clinical trials performed thus far may provide important information for the selection of appropriate biological agents, and therefore, we have extensively reviewed such trials in the present study. |
Publish Date |
2014-10-07 17:32 |
Citation |
Seo GS, Chae SC. Biological therapy for ulcerative colitis: An update. World J Gastroenterol 2014; 20(37): 13234-13238 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i37/13234.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i37.13234 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345